Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05288998 · ClinicalTrials.gov registry record
Intrarenal Microvasculature in ADPKD
A clinical trial of Autosomal Dominant Polycystic Kidney Disease, sponsored by Mayo Clinic.
- Active
- Registry status
- 34
- Enrollment target
- 1
- Study location
NCT05288998: Active study of Autosomal Dominant Polycystic Kidney Disease, sponsored by Mayo Clinic.
NCT05288998 is a study of Autosomal Dominant Polycystic Kidney Disease that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 34 participants, below the 158-participant average among 9 other Autosomal Dominant Polycystic Kidney Disease trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05288998, a study of Autosomal Dominant Polycystic Kidney Disease, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to evaluate the use of Super-resolution ultrasound (SRU) to assess the intrarenal microvasculature in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and healthy volunteers.
Primary Outcome
Renal vessel density as percentage, determined by SRU.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-11-30 |
| Est. Completion | 2026-12 |
What the registry record for NCT05288998 still lists
NCT05288998 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 158-participant average among 9 other Autosomal Dominant Polycystic Kidney Disease trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Autosomal Dominant Polycystic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05288998 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05288998 about?
NCT05288998 is a clinical study titled "Intrarenal Microvasculature in ADPKD". The primary objective of this study is to evaluate the use of Super-resolution ultrasound (SRU) to assess the intrarenal microvasculature in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and healthy volunteers.
What is the current status of trial NCT05288998?
This trial is currently active not recruiting. The enrollment target is 34 participants. The study started on 2021-11-30. Estimated completion is 2026-12.
What conditions does trial NCT05288998 study?
This clinical trial studies the following conditions: Autosomal Dominant Polycystic Kidney Disease.
Who is sponsoring clinical trial NCT05288998?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05288998 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autosomal Dominant Polycystic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05288998's enrollment target sits among peer trials
34 9th of 9 higher than 1 of 9 other Autosomal Dominant Polycystic Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autosomal Dominant Polycystic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
RECRUITING
-
NOX4 and Related Biomarkers in ADPKD
RECRUITING
-
A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
RECRUITING · Phase 2
-
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
RECRUITING · Phase 1
-
A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD
ACTIVE NOT RECRUITING
-
Role of ROS and cAMP-PKA Biomarkers in ADPKD
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI